Publication date: Mar 22, 2025
The COVID-19 pandemic resulted in the rapid development and distribution of vaccines as a critical strategy to control the spread of the virus. This paper explores COVID-19 vaccine uptake in the state of Ohio, with a particular focus on the difference between metro and non-metro residents. Survey data collected as part of the IMPACT-Ohio Project were used for this study. From August 2021 to February 2023, 3,806 individuals who resided in 12 Ohio counties (six metro and six non-metro counties) responded to the survey. Chi-square tests compared the relationships between various demographic, socio-economic and clinical characteristics among metro and non-metro region respondents. Binary logistic regression modeled the probability of receipt of COVID-19 vaccine and compared those Ohioans who lived in metro (RUCC codes 1-3) vs non-metro (RUCC codes 4-9) counties with adjustment of various covariates. Participants residing in metro counties were almost two times more likely to receive the COVID-19 vaccine compared to those living in non-metro counties adjusting for demographic, socioeconomic and clinical characteristics (aOR: 1. 89, 95% CI: 1. 38-2. 58, P
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 |
pathway | REACTOME | Reproduction |
disease | MESH | tics |
disease | MESH | education level |
drug | DRUGBANK | Coenzyme M |
disease | IDO | intervention |
drug | DRUGBANK | Pentaerythritol tetranitrate |
disease | MESH | infections |
disease | MESH | Long COVID |
disease | MESH | panic |
drug | DRUGBANK | Trestolone |
disease | IDO | history |
drug | DRUGBANK | Indoleacetic acid |
disease | MESH | confusion |
drug | DRUGBANK | Fenamole |
disease | MESH | arc |
drug | DRUGBANK | 3 7 11 15-Tetramethyl-Hexadecan-1-Ol |